Bolt Biotherapeutics, Inc.
NASDAQ: BOLT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- William Quinn
- Employees
- 52
- Headquarters
- Redwood City, United States
- IPO year
- 2021
- Market cap
- $8.1M
- Website
- https://www.boltbio.com
Loading BOLT…
Loading profile data…Frequently asked questions about BOLT
What does Bolt Biotherapeutics, Inc. (BOLT) do?
Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the body's immune system to identify and eliminate cancerous cells. A key therapeutic in its pipeline is BDC-1001, an investigational treatment targetin...
Where does BOLT trade?
Bolt Biotherapeutics, Inc. (BOLT) trades on the NASDAQ Global Select.
What sector is BOLT in?
Bolt Biotherapeutics, Inc. (BOLT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Bolt Biotherapeutics, Inc.?
William Quinn is the chief executive officer of Bolt Biotherapeutics, Inc. (BOLT).
Where is Bolt Biotherapeutics, Inc. headquartered?
Bolt Biotherapeutics, Inc. is headquartered in United States.
Does BOLT pay a dividend?
Bolt Biotherapeutics, Inc. (BOLT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BOLT go public?
Bolt Biotherapeutics, Inc. (BOLT) completed its initial public offering in 2021.